Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Health Information Services Average | - - | - - | - - | 6,458.78 | 597.65 | 50.65 | -269.52 | 41.04 | 0.05 | -16.4946 | 0.19 | -46.9748 | -12.1874 | 0.80 | 3.12 | 269.6696 | - - | ||
Maximum | - - | - - | - - | 40,948.00 | 4,650.00 | 600.00 | 2,902.00 | 755.00 | 0.92 | 188.7388 | 3.41 | 85.6400 | 296.0100 | 34.45 | 95.78 | 1,065.6800 | - - | ||
Minimum | - - | - - | - - | 15.00 | 0.00 | -101.00 | -8,941.00 | -328.00 | 0.00 | -686.1604 | -1.26 | -1,945.5600 | -314.6500 | -13.64 | -25.18 | 0.0000 | - - | ||
Guardant Health, Inc. GH | 25.61 | 0.53 2.10% | 183 vs. 2,203 | 3,149.00 | 168.00 | -114.00 | -37.00 | -2,256.00 | -0.9400 | -5.3587 | 0.00 | 61.25 | -68.24 | -168.39 | -6.75 | 551.71 | 123.00 | ||
Beam Therapeutics Inc. BEAM | 26.37 | 0.86 3.37% | 62 vs. 1,081 | 2,173.00 | 7.00 | -98.00 | -102.00 | -1,288.00 | -1.2100 | -6.7607 | 0.00 | 26.71 | -1331.57 | -10.80 | -7.26 | 584.64 | 82.00 | ||
10x Genomics, Inc. TXG | 23.69 | 1.61 7.29% | 215 vs. 1,840 | 2,854.00 | 141.00 | -59.00 | -18.00 | -1,344.00 | -0.5000 | -18.4472 | 0.00 | 67.78 | -42.52 | -8.34 | -6.50 | 425.92 | 120.00 |